Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281874430> ?p ?o ?g. }
- W4281874430 endingPage "1192" @default.
- W4281874430 startingPage "1167" @default.
- W4281874430 abstract "Abstract: Gliomas are the most common malignant cancers of the brain that have unregulated proliferation and are known as highly invasive tumors. Hence, their relapse rate is high, and the prognosis is low. Despite remarkable advances in neuroimaging, neurosurgery, and radiation therapy, they, especially glioblastoma, are highly resistant to treatments, including radiotherapy, surgery, and temozolomide chemotherapy. The average survival rate for patients with malignant glioma is still less than two years. Accordingly, the search for new treatment options has recently become an urgent need. Today, a number of nutraceuticals have been considered because of their special role in inhibiting the angiogenic process, metastasis, and apoptosis, resulting in the inhibition of tumor growth, including glioma. Nutraceuticals can disrupt cancer cells by affecting different pathways. In fact, these compounds can reduce the growth of cancer cells, inhibit their proliferation and angiogenesis, as well as induce apoptosis in these cells and play an important role in various stages of treatment. One of the key targets of nutraceuticals may be to regulate cellular signaling pathways, such as PI3K/Akt/mTORC1, JAK/STAT, and GSK-3, or to exert their effects through other mechanisms, such as cytokine receptors and inflammatory pathways, reactive oxygen species, and miRNAs. This review refers to the results of recent studies and target molecules as well as signaling pathways affected by some nutraceuticals in glioma cells. These studies indicated that clinical trials are imminent and new approaches can be beneficial for patients." @default.
- W4281874430 created "2022-06-13" @default.
- W4281874430 creator A5014266158 @default.
- W4281874430 creator A5019352148 @default.
- W4281874430 creator A5041633995 @default.
- W4281874430 creator A5044017384 @default.
- W4281874430 creator A5065652905 @default.
- W4281874430 creator A5072791138 @default.
- W4281874430 creator A5091709020 @default.
- W4281874430 date "2023-06-01" @default.
- W4281874430 modified "2023-10-17" @default.
- W4281874430 title "Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence and Perspectives" @default.
- W4281874430 cites W1484380728 @default.
- W4281874430 cites W1551640784 @default.
- W4281874430 cites W1686797737 @default.
- W4281874430 cites W1766156668 @default.
- W4281874430 cites W1800389686 @default.
- W4281874430 cites W1820010087 @default.
- W4281874430 cites W1824652155 @default.
- W4281874430 cites W1932600137 @default.
- W4281874430 cites W1947521409 @default.
- W4281874430 cites W1965103740 @default.
- W4281874430 cites W1966700699 @default.
- W4281874430 cites W1968262266 @default.
- W4281874430 cites W1969910856 @default.
- W4281874430 cites W1972355779 @default.
- W4281874430 cites W1972476428 @default.
- W4281874430 cites W1972489193 @default.
- W4281874430 cites W1973703381 @default.
- W4281874430 cites W1973930904 @default.
- W4281874430 cites W1975965382 @default.
- W4281874430 cites W1977191081 @default.
- W4281874430 cites W1978775082 @default.
- W4281874430 cites W1980959570 @default.
- W4281874430 cites W1983200739 @default.
- W4281874430 cites W1984985876 @default.
- W4281874430 cites W1985800268 @default.
- W4281874430 cites W1986194005 @default.
- W4281874430 cites W1989863622 @default.
- W4281874430 cites W1992301683 @default.
- W4281874430 cites W1993576370 @default.
- W4281874430 cites W1993897315 @default.
- W4281874430 cites W1998561093 @default.
- W4281874430 cites W1999816548 @default.
- W4281874430 cites W2002293694 @default.
- W4281874430 cites W2006993970 @default.
- W4281874430 cites W2008212933 @default.
- W4281874430 cites W2008585615 @default.
- W4281874430 cites W2008960710 @default.
- W4281874430 cites W2009085926 @default.
- W4281874430 cites W2011559405 @default.
- W4281874430 cites W2012150747 @default.
- W4281874430 cites W2013585426 @default.
- W4281874430 cites W2015038184 @default.
- W4281874430 cites W2017051249 @default.
- W4281874430 cites W2020969670 @default.
- W4281874430 cites W2026294697 @default.
- W4281874430 cites W2030133707 @default.
- W4281874430 cites W2030686490 @default.
- W4281874430 cites W2030933825 @default.
- W4281874430 cites W2033617366 @default.
- W4281874430 cites W2035703596 @default.
- W4281874430 cites W2038156536 @default.
- W4281874430 cites W2041384877 @default.
- W4281874430 cites W2043547500 @default.
- W4281874430 cites W2043813949 @default.
- W4281874430 cites W2045586794 @default.
- W4281874430 cites W2046603236 @default.
- W4281874430 cites W2047972729 @default.
- W4281874430 cites W2056753605 @default.
- W4281874430 cites W2058032884 @default.
- W4281874430 cites W2060097272 @default.
- W4281874430 cites W2069724685 @default.
- W4281874430 cites W2069996640 @default.
- W4281874430 cites W2071576628 @default.
- W4281874430 cites W2074951329 @default.
- W4281874430 cites W2078071390 @default.
- W4281874430 cites W2078991002 @default.
- W4281874430 cites W2079565353 @default.
- W4281874430 cites W2079797200 @default.
- W4281874430 cites W2079927834 @default.
- W4281874430 cites W2084276537 @default.
- W4281874430 cites W2085219442 @default.
- W4281874430 cites W2086211695 @default.
- W4281874430 cites W2091286425 @default.
- W4281874430 cites W2091574965 @default.
- W4281874430 cites W2092692114 @default.
- W4281874430 cites W2092899988 @default.
- W4281874430 cites W2094197774 @default.
- W4281874430 cites W2094385925 @default.
- W4281874430 cites W2095999479 @default.
- W4281874430 cites W2097690401 @default.
- W4281874430 cites W2098339185 @default.
- W4281874430 cites W2099033106 @default.
- W4281874430 cites W2105435654 @default.
- W4281874430 cites W2110044462 @default.
- W4281874430 cites W2111842868 @default.
- W4281874430 cites W2115218756 @default.